|
LDB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.493640E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.760300E-03 |
| Normal-vs-Stage2 |
4.348000E-01 |
| Normal-vs-Stage3 |
2.479200E-01 |
| Normal-vs-Stage4 |
7.245700E-02 |
| Stage1-vs-Stage2 |
2.188000E-01 |
| Stage1-vs-Stage3 |
1.140760E-01 |
| Stage1-vs-Stage4 |
6.126200E-01 |
| Stage2-vs-Stage3 |
9.286800E-01 |
| Stage2-vs-Stage4 |
4.822200E-01 |
| Stage3-vs-Stage4 |
4.442600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.635940E-02 |
| Normal-vs-AfricanAmerican |
3.001000E-03 |
| Normal-vs-Asian |
1.375660E-02 |
| Caucasian-vs-AfricanAmerican |
1.140770E-01 |
| Caucasian-vs-Asian |
2.976000E-01 |
| AfricanAmerican-vs-Asian |
5.049600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.421800E-02 |
| Normal-vs-Female |
1.952010E-02 |
| Male-vs-Female |
9.053800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.800500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.437700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.220760E-01 |
| Normal-vs-Age(81-100Yrs) |
5.915800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.882800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.263400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.501200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.905200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.413800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.140400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.039500E-03 |
| Classical-VS-Follicular |
7.358100E-03 |
| Classical-VS-Other |
5.430600E-01 |
| Classical-VS-Normal |
6.584200E-04 |
| Tall-VS-Follicular |
6.923000E-01 |
| Tall-VS-Other |
6.255400E-01 |
| Tall-VS-Normal |
9.376600E-01 |
| Follicular-VS-Other |
7.250000E-01 |
| Follicular-VS-Normal |
7.323800E-01 |
| Other-VS-Normal |
5.119400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.656500E-02 |
| Normal-vs-N1 |
7.618200E-02 |
| N0-vs-N1 |
8.400400E-01 |
|
|
